Cellect Biotechnology
Kfar Saba
About Cellect Biotechnology
Cellect is an emerging biotechnology company that is developing a novel technology platform known as Powered by CellectTM that functionally selects stem cells from a mixed population of cells in order to improve the safety and efficacy of regenerative medicine stem cell therapies. We aim to become the standard enabling technology for the enrichment of the stem cell population for companies developing stem cell therapies, physicians practicing regenerative medicine, and for researchers and academia engaged in stem cell research.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.0M
- Last round: Series Unknown (Feb 2016)
- Website: cellect.co
- Phone: 97299741444
Industries & Categories
Biopharma, Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/cellect-biotechnology-143259 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.